dc.contributor.author |
El-Bitar M.K. |
dc.contributor.author |
Muwakkit S.A. |
dc.contributor.author |
Abboud M.R. |
dc.contributor.author |
Sawaya R.A. |
dc.contributor.author |
Boustany R.-M. |
dc.contributor.editor |
|
dc.date |
Aug-2010 |
dc.date.accessioned |
2017-10-05T16:01:07Z |
dc.date.available |
2017-10-05T16:01:07Z |
dc.date.issued |
2010 |
dc.identifier |
10.1177/0883073809356108 |
dc.identifier.isbn |
|
dc.identifier.issn |
08830738 |
dc.identifier.uri |
http://hdl.handle.net/10938/19336 |
dc.description.abstract |
Morvan syndrome is a rare autoimmune disease named after the French physician Augustin Marie Morvan. It is characterized by multiple, irregular contractions of the long muscles, weakness, pruritus, hyperhidrosis, insomnia, and delirium. Here, we describe a 17-year-old young man, previously diagnosed with B-cell lymphoma, who presented with multiple asynchronous fasciculations of the long muscles of his lower extremities accompanied by numbness. The patient responded initially to pulse corticosteroids with diminution of the fasciculations. He achieved complete remission following 7 consecutive, monthly intravenous immunoglobulin injections. The present case is described in the context of the available literature. © The Author(s) 2010. |
dc.format.extent |
|
dc.format.extent |
Pages: (1038-1041) |
dc.language |
English |
dc.publisher |
THOUSAND OAKS |
dc.relation.ispartof |
Publication Name: Journal of Child Neurology; Publication Year: 2010; Volume: 25; no. 8; Pages: (1038-1041); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Morvan syndrome following B-cell lymphoma |
dc.type |
Article |
dc.contributor.affiliation |
El-Bitar, M.K., Department of Pediatrics, Pediatric Epilepsy Program, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.affiliation |
Muwakkit, S.A., Childrens' Cancer Center of Lebanon, Beirut, Lebanon |
dc.contributor.affiliation |
Abboud, M.R., Childrens' Cancer Center of Lebanon, Beirut, Lebanon |
dc.contributor.affiliation |
Sawaya, R.A., Department of Internal Medicine, Medical Center, American University of Beirut, Beirut, Lebanon |
dc.contributor.affiliation |
Boustany, R.-M., Department of Pediatrics, Pediatric Epilepsy Program, American University of Beirut Medical Center, Beirut, Lebanon |
dc.contributor.authorAddress |
Boustany, R.-M.; American University of Beirut, PO Box 11-0236, Riad El Solh, 11072020 Beirut, Lebanon; email: rb50@aub.edu.lb |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Pediatrics and Adolescent Medicine; |
dc.contributor.authorDepartment |
Pediatrics and Adolescent Medicine |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
rb50@aub.edu.lb |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
El-Bitar, MK |
dc.contributor.authorInitials |
Muwakkit, SA |
dc.contributor.authorInitials |
Abboud, MR |
dc.contributor.authorInitials |
Sawaya, RA |
dc.contributor.authorInitials |
Boustany, RM |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Boustany, RM (reprint author), Amer Univ Beirut, Med Ctr, Div Pediat Neurol, Pediat Epilepsy Program,Dept Pediat, POB 11-0236, Beirut 11072020, Lebanon. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
Barber PA, 2000, NEUROLOGY, V54, P771; FISCHERP.C, 1974, REV NEUROL, V130, P111; GIL R, 1984, REV NEUROL, V140, P728; HALBACH M, 1987, J NEUROL, V234, P433, DOI 10.1007-BF00314093; HAUG BA, 1989, CLIN NEUROL NEUROSUR, V91, P53, DOI 10.1016-S0303-8467(89)80008-3; IWASAKI Y, 1990, EUR ARCH PSY CLIN N, V239, P335, DOI 10.1007-BF01735061; Josephs KA, 2004, J CLIN NEUROPHYSIOL, V21, P440, DOI 10.1097-00004691-200411000-00008; Kimura J., 1989, ELECTRODIAGNOSIS DIS; Lee EK, 1998, J NEUROL NEUROSUR PS, V65, P857, DOI 10.1136-jnnp.65.6.857; Liguori R, 2001, BRAIN, V124, P2417, DOI 10.1093-brain-124.12.2417; Madrid A, 1996, J NEUROL, V243, P350, DOI 10.1007-BF00868410; Morvan A., 1890, GAZ HEBD MED CHIR, V27, P173; VERNAY D, 1986, ARTHRITIS RHEUM, V29, P1413, DOI 10.1002-art.1780291119 |
dc.description.citedCount |
|
dc.description.citedTotWOSCount |
0 |
dc.description.citedWOSCount |
0 |
dc.format.extentCount |
4 |
dc.identifier.articleNo |
|
dc.identifier.coden |
JOCNE |
dc.identifier.pubmedID |
20110220 |
dc.identifier.scopusID |
77954730210 |
dc.identifier.url |
|
dc.publisher.address |
2455 TELLER RD, THOUSAND OAKS, CA 91320 USA |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
J. Child Neurol. |
dc.relation.ispartOfIssue |
8 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Journal of Child Neurology |
dc.relation.ispartofPubTitleAbbr |
J. Child Neurol. |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
25 |
dc.source.ID |
WOS:000279908100019 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
B-cell lymphoma |
dc.subject.otherAuthKeyword |
intravenous immunoglobulins |
dc.subject.otherAuthKeyword |
Morvan syndrome |
dc.subject.otherAuthKeyword |
steroids |
dc.subject.otherChemCAS |
cyclophosphamide, 50-18-0 |
dc.subject.otherChemCAS |
gabapentin, 60142-96-3 |
dc.subject.otherChemCAS |
immunoglobulin, 9007-83-4 |
dc.subject.otherChemCAS |
mesna, 19767-45-4, 3375-50-6 |
dc.subject.otherChemCAS |
methotrexate, 15475-56-6, 59-05-2, 7413-34-5 |
dc.subject.otherChemCAS |
methylprednisolone, 6923-42-8, 83-43-2 |
dc.subject.otherChemCAS |
prednisone, 53-03-2 |
dc.subject.otherChemCAS |
vincristine, 57-22-7 |
dc.subject.otherChemCAS |
Autoantibodies |
dc.subject.otherChemCAS |
Immunoglobulins, Intravenous |
dc.subject.otherChemCAS |
Methylprednisolone, 83-43-2 |
dc.subject.otherIndex |
antihypertensive agent |
dc.subject.otherIndex |
cholinergic receptor antibody |
dc.subject.otherIndex |
cyclophosphamide |
dc.subject.otherIndex |
gabapentin |
dc.subject.otherIndex |
gliadin antibody |
dc.subject.otherIndex |
immunoglobulin |
dc.subject.otherIndex |
immunoglobulin A antibody |
dc.subject.otherIndex |
immunoglobulin G antibody |
dc.subject.otherIndex |
mesna |
dc.subject.otherIndex |
methotrexate |
dc.subject.otherIndex |
methylprednisolone |
dc.subject.otherIndex |
potassium channel blocking agent |
dc.subject.otherIndex |
prednisone |
dc.subject.otherIndex |
thyroglobulin antibody |
dc.subject.otherIndex |
vincristine |
dc.subject.otherIndex |
adolescent |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
autoimmune disease |
dc.subject.otherIndex |
B cell lymphoma |
dc.subject.otherIndex |
Babinski reflex |
dc.subject.otherIndex |
cancer chemotherapy |
dc.subject.otherIndex |
cancer regression |
dc.subject.otherIndex |
case report |
dc.subject.otherIndex |
constipation |
dc.subject.otherIndex |
delirium |
dc.subject.otherIndex |
disease course |
dc.subject.otherIndex |
drug pulse therapy |
dc.subject.otherIndex |
drug withdrawal |
dc.subject.otherIndex |
electrophysiology |
dc.subject.otherIndex |
fasciculation |
dc.subject.otherIndex |
functional assessment |
dc.subject.otherIndex |
heart palpitation |
dc.subject.otherIndex |
heavy metal poisoning |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
hyperhidrosis |
dc.subject.otherIndex |
hypersalivation |
dc.subject.otherIndex |
hypertension |
dc.subject.otherIndex |
immunotherapy |
dc.subject.otherIndex |
insomnia |
dc.subject.otherIndex |
leg cramp |
dc.subject.otherIndex |
limb pain |
dc.subject.otherIndex |
male |
dc.subject.otherIndex |
morvan syndrome |
dc.subject.otherIndex |
motor nerve conduction |
dc.subject.otherIndex |
muscle contraction |
dc.subject.otherIndex |
neurography |
dc.subject.otherIndex |
neurologic disease |
dc.subject.otherIndex |
nuclear magnetic resonance imaging |
dc.subject.otherIndex |
paresthesia |
dc.subject.otherIndex |
physical examination |
dc.subject.otherIndex |
priority journal |
dc.subject.otherIndex |
pruritus |
dc.subject.otherIndex |
remission |
dc.subject.otherIndex |
screening |
dc.subject.otherIndex |
sensory nerve conduction |
dc.subject.otherIndex |
skin tingling |
dc.subject.otherIndex |
treatment duration |
dc.subject.otherIndex |
treatment outcome |
dc.subject.otherIndex |
treatment response |
dc.subject.otherIndex |
urine retention |
dc.subject.otherIndex |
weakness |
dc.subject.otherIndex |
Adolescent |
dc.subject.otherIndex |
Autoantibodies |
dc.subject.otherIndex |
Electrodiagnosis |
dc.subject.otherIndex |
Fasciculation |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Hyperesthesia |
dc.subject.otherIndex |
Immunoglobulins, Intravenous |
dc.subject.otherIndex |
Lymphoma, B-Cell |
dc.subject.otherIndex |
Male |
dc.subject.otherIndex |
Methylprednisolone |
dc.subject.otherIndex |
Muscle Cramp |
dc.subject.otherIndex |
Muscle, Skeletal |
dc.subject.otherIndex |
Myokymia |
dc.subject.otherIndex |
Neural Conduction |
dc.subject.otherIndex |
Peripheral Nerves |
dc.subject.otherIndex |
Pulse Therapy, Drug |
dc.subject.otherIndex |
Sleep Initiation and Maintenance Disorders |
dc.subject.otherIndex |
Treatment Outcome |
dc.subject.otherKeywordPlus |
FIBRILLARY CHOREA |
dc.subject.otherKeywordPlus |
ANTIBODIES |
dc.subject.otherKeywordPlus |
THYMOMA |
dc.subject.otherWOS |
Clinical Neurology |
dc.subject.otherWOS |
Pediatrics |